欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/0992/004
药品名称
Ceftriaxona Hospira
活性成分
ceftriaxone sodium salt 2.0 g
剂型
Powder for solution for infusion/injection
上市许可持有人
Hospira UK Limited
参考成员国 - 产品名称
Portugal (PT)
Ceftriaxona Hospira
互认成员国 - 产品名称
Bulgaria (BG)
Malta (MT)
Poland (PL)
Romania (RO)
Lithuania (LT)
Latvia (LV)
Estonia (EE)
Slovenia (SI)
Belgium (BE)
Ceftriaxone Hospira 2 g Poeder voor oplossing voor infusie
United Kingdom (Northern Ireland) (XI)
Ceftriaxona Hospira
Italy (IT)
Cyprus (CY)
CEFTRIAXONE HOSPIRA PWD FOR SOL FOR INJ/INF
Slovakia (SK)
许可日期
2014/01/22
最近更新日期
2024/05/28
药物ATC编码
J01DD04 ceftriaxone
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
common_impack
Date of last change:2024/09/06
Final PL
|
common_pl
Date of last change:2024/09/06
Final SPC
|
common_spc
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase